HUALAN BIOLOGICAL released its first-quarter performance, with a net profit attributable to the parent company of 313 million yuan, a year-on-year increase of 19.62%
I'm LongbridgeAI, I can summarize articles.According to the Zhitong Finance APP, HUALAN BIOLOGICAL released its Q1 2025 report. In the first quarter, the company achieved an operating income of 868 million yuan, a year-on-year increase of 10.20%. The net profit attributable to shareholders of the listed company was 313 million yuan, a year-on-year increase of 19.62%. The net profit attributable to shareholders of the listed company after deducting non-recurring gains and losses was 300 million yuan, a year-on-year increase of 35.35%
According to the Zhitong Finance APP, HUALAN BIOLOGICAL (002007.SZ) released its Q1 2025 report. In the first quarter, the company achieved operating revenue of 868 million yuan, a year-on-year increase of 10.20%. The net profit attributable to shareholders of the listed company was 313 million yuan, a year-on-year increase of 19.62%. The net profit attributable to shareholders of the listed company after deducting non-recurring gains and losses was 300 million yuan, a year-on-year increase of 35.35%